Table 2.
Metabolites affected by CCRT and RT. Presented are metabolites that changed their levels significantly (FDR < 0.05) between specified time points in both treatment modalities.
| Metabolites | RT | CCRT |
| Ratio B/A | ||
| PC aa C34:2 | 0.847 | 0.809 |
| PC aa C36:3 | 0.854 | 0.713 |
| PC ae C36:3 | 0.854 | 0.652 |
| PC ae C38:4 | 0.876 | 0.779 |
| PC ae C38:5 | 0.873 | 0.776 |
| Ratio C/B | ||
| SM (OH) C16:1 | 1.245 | 1.387 |
| SM C18:0 | 1.301 | 1.421 |
| Ratio C/A | ||
| C0 | 0.869 | 0.895 |
| His | 0.797 | 0.742 |
| Pro | 0.868 | 0.792 |
| Kynurenine | 0.775 | 0.756 |
| lysoPC a C20:3 | 0.787 | 0.668 |
| PC aa C36:3 | 0.714 | 0.719 |
| PC aa C38:3 | 0.687 | 0.733 |
| PC aa C40:5 | 0.774 | 0.720 |
| PC ae C36:3 | 0.783 | 0.780 |
| PC ae C38:3 | 0.815 | 0.843 |
| PC ae C38:4 | 0.835 | 0.872 |
| SM (OH) C16:1 | 1.270 | 1.322 |
| SM C18:0 | 1.289 | 1.347 |
| SM C24:0 | 0.825 | 0.756 |